Table 2 Characteristics of the allo-HSCT procedure
Recipient features | Donor features | HSCT characteristics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pt. no | Age | Sex | Age | Sex | Donor type | ABO status | SC source | Conditioning regimen | Graft volume (cc) | MNC dose/kg (× 108) | CD3+ dose/kg (× 108) | CD34+ dose/kg (× 106) | GVHD prophylaxis |
1 | 16 | M | 15 | M | MSD | Matched | PB | BuCy | 500 | 7.5 | 3.86 | 2.8 | CyA/MTX |
2 | 6 | M | 35 | M | MSD | Mismatched | PB | BuCy + ATG | 106 | 8.0 | 4.21 | 4.4 | CyA/MTX |
3 | 7 | F | 13 | M | MSD | Mismatched | PB | BuCy | 150 | 8.0 | 2.17 | 5.4 | CyA/MTX |
4 | 4.5 | M | 21 | F | MSD | Matched | PB | BuCy | 99 | 8.0 | 1.96 | 9.7 | CyA/MTX |